Prosidyan, Inc.

12 patents currently held · Updated Nov 14, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Mar 2031

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Jan 2, 2027
The maintenance fee for Bioactive porous bone graft implants (US 10,335,516) comes due Jan 2, 2027. Unpaid by Jul 2, 2027, it lapses early.
1 fee due May 19, 2027
The maintenance fee for Bone graft implants containing allograft (US 10,478,528) comes due May 19, 2027. Unpaid by Nov 19, 2027, it lapses early.
1 fee due Jun 10, 2027
The maintenance fee for Bioactive porous bone graft compositions with collagen (US 10,500,312) comes due Jun 10, 2027. Unpaid by Dec 10, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 11,338,061	Dynamic bioactive bone graft material having an engineered porosity In force Term ends Mar 16, 2031 · From the USPTO record	In force	Term ends Mar 16, 2031	From the USPTO record
US 8,567,162	Dynamic bioactive bone graft material and methods for handling In force Term ends Apr 10, 2032 · From the USPTO record	In force	Term ends Apr 10, 2032	From the USPTO record
US 10,478,528	Bone graft implants containing allograft In force Ends no later than Mar 14, 2033 · From the USPTO record	In force	Ends no later than Mar 14, 2033	From the USPTO record
US 11,129,925	Bioactive porous bone graft implants In force Term ends Mar 14, 2033 · From the USPTO record	In force	Term ends Mar 14, 2033	From the USPTO record
US 12,083,247	Bioactive porous bone graft implants In force Term ends Apr 5, 2033 · From the USPTO record	In force	Term ends Apr 5, 2033	From the USPTO record
US 8,883,195	Bioactive porous bone graft implants In force Term ends Apr 11, 2033 · From the USPTO record	In force	Term ends Apr 11, 2033	From the USPTO record
US 8,889,178	Bioactive porous bone graft compositions in synthetic containment In force Term ends May 18, 2033 · From the USPTO record	In force	Term ends May 18, 2033	From the USPTO record
US 10,500,312	Bioactive porous bone graft compositions with collagen In force Term ends May 19, 2033 · From the USPTO record	In force	Term ends May 19, 2033	From the USPTO record
US 9,381,274	Bone graft implants containing allograft In force Term ends Jul 8, 2033 · From the USPTO record	In force	Term ends Jul 8, 2033	From the USPTO record
US 9,814,804	Method of dose controlled application of bone graft materials by weight In force Ends no later than Aug 2, 2033 · From the USPTO record	In force	Ends no later than Aug 2, 2033	From the USPTO record

10 of 12 patents shown.

Pro members see all 12.

Pro members: see all 12 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

7 no status recorded

List them